Table 2

Laboratory data on patients with multicentric Castleman's disease

Patient noIgG1 (mg/dl) (320–748)*IgG2 (mg/dl) (208–754)*IgG3 (mg/dl) (6.6–88.3)*IgG4 (mg/dl) (4.8–105)*IgG4/IgG (%) (3–6)*IgG (mg/dl) (870–1700)*IgA (mg/dl) (110–410)*IgM (mg/dl) (35–220)*IgE (IU/ml) (<170)*CRP (mg/dl) (<0.3)*IL-6 (pg/ml) (<4.0)*LDH (IU/l) (119–229)*sIL-2R (U/ml) (220–530)*Hb (g/dl) (male, 13.5–17.6)* (female, 11.3–15.2)*Alb (g/dl) (4.0–5.0)*T-cho (mg/dl) (150–219)*
118301810270932.34003620.1139.2ND2.848.6119181212.73.4142
220801270941474.13591104913516709.319.6143108013.23.6103
3NDNDND1544.93113352106ND7.2127.410321377.52.2117
4329013101683146.25082898229ND9.331.213337978.11.8114
5NDNDND146017.48380638263ND10.063091164410.92.2ND
63810221055.878911.57957693162ND6.2617.311022009.43.091
  • * Normal range or value (in the respective unit).

  • Alb, albumin; CRP, C-reactive protein; Hb, haemoglobin; Ig, immunoglobulin; IL-6, interleukin-6; LDH, lactate dehydrogenase; ND, not determined; sIL-2R, soluble interleukin-2 receptor; T-cho, total cholesterol.